908 Devices Inc. (MASS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
46.44-3.76 (-7.48%)
As of 12:18PM EST. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 50.20 |
| Open | 49.46 |
| Bid | 46.47 x 1100 |
| Ask | 46.94 x 900 |
| Day's Range | 46.14 - 50.51 |
| 52 Week Range | 43.25 - 79.60 |
| Volume | 224,680 |
| Avg. Volume | 368,788 |
| Market Cap | 1.217B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Mar 30, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 67.50 |
- Business Wire
908 Devices Appoints Jeff George and Fenel Eloi to its Board of Directors
Company adds two directors with financial, pharmaceutical, and consumable business expertise.
- Business Wire
908 Devices to Report Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021
908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the fourth quarter and full year of 2020 before market open on Tuesday, March 30, 2021. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
- Business Wire
908 Devices to Participate in Upcoming Investor Conferences
908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following virtual investor conferences.
© 2021 Verizon Media. All rights reserved.
